Aktive Positionen von Mark Versavel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Vzenium LLC | Gründer | - | - |
Präsident | - | - |
Karriereverlauf von Mark Versavel
Ehemalige bekannte Positionen von Mark Versavel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ELIEM THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2023 | 01.10.2023 |
Cavion, Inc.
Cavion, Inc. Pharmaceuticals: MajorHealth Technology Cavion, Inc. engages in development of pharmaceuticals products. It produces oncology drugs to treat solid tumors that selectively inhibits the t-type calcium channel. The company was founded by Andrew J. Krouse, Lloyd S. Gray, and Timothy L. Macdonald in 2005 and is headquartered in Charlottesville, VA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
NEUROBO PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2019 | - |
ALZHEON, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Mark Versavel
University of Antwerp | Doctorate Degree |
Humboldt-Universität zu Berlin | Doctorate Degree |
University of Michigan | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Belgien | 2 |
Deutschland | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Doctorate Degree | 2 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NEUROBO PHARMACEUTICALS, INC. | Health Technology |
ELIEM THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Alzheon, Inc.
Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
Cavion, Inc.
Cavion, Inc. Pharmaceuticals: MajorHealth Technology Cavion, Inc. engages in development of pharmaceuticals products. It produces oncology drugs to treat solid tumors that selectively inhibits the t-type calcium channel. The company was founded by Andrew J. Krouse, Lloyd S. Gray, and Timothy L. Macdonald in 2005 and is headquartered in Charlottesville, VA. | Health Technology |
Vzenium LLC |
- Börse
- Insiders
- Mark Versavel
- Erfahrung